Sort
130,381 grants matching “hiv”
Innate, Transcriptomic, and Microbiomic correlates of TB infection
$898,096Michael Haggai Glickman · Weill Medical Coll Of Cornell Univ · U19 · FY2018 · AI
Preclinical Development of MucoCept
$898,037Craig R Cohen · University Of California, San Francisco · U01 · FY2015 · AI
Cannabinoid inhibition of CNS inflammasome activation via modulation of the gut-brain axis
$898,025Siddappa N Byrareddy · University Of Nebraska Medical Center · R01 · FY2025 · DA
Improving retention along the hypertension care cascade and reducing cardiovascular risk among people with HIV who use a safety net clinic
$897,989Elise D Riley · University Of California, San Francisco · R01 · FY2025 · MD
HIV Surveillance
$897,980Aaron James Roome · Connecticut State Dept Of Public Health · U62 · FY2013 · PS
Clinical optimization of a tenofovir enema and adherence tracking
$897,929Craig Walter Hendrix · Johns Hopkins University · U19 · FY2015 · AI
Impact of a novel HIV peer navigationand overdose prevention intervention on engagement in the HIV prevention and treatment cascade.
$897,928Susan Gail Sherman · Johns Hopkins University · R01 · FY2022 · DA
Nonhuman Primate Core
$897,927Hans-Peter Kiem · University Of California Los Angeles · U19 · FY2021 · AI
METHADONE AND HIV/AIDS DRUG INTERACTIONS
$897,904University Of Washington · M01 · FY2004 · RR
HIV/STD PREVENTION INTERVENTIONS FOR BLACK ADOLESCENTS
$897,819University Of Pennsylvania · R01 · FY2001 · MH
NONHUMAN PRIMATE PURCHASE AND HOLDING
$897,758Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2018 · AI
Mobilizing host defenses to lymphoid sites of HIV persistence to induce remission
$897,741Mirko Paiardini · Emory University · R56 · FY2020 · AI
PATHOGENESIS OF MUCOSAL TRANSMISSION/ACUTE SIV INFECTION
$897,733University Of Minnesota Twin Cities · R01 · FY2002 · AI
HIV RNase H natural product inhibitors
$897,728Michael A Parniak · University Of Pittsburgh At Pittsburgh · U19 · FY2011 · AI
CELL BIOLOGY OF MYCOBACTERIUM AVIUM INFECTION
$897,530University Of California San Francisco · P01 · FY2001 · AI
R5 SHIV/Macaque Models for the Evaluation of T and B Cell-Based HIV-1 Vaccines
$897,508Cecilia C Cheng-Mayer · Aaron Diamond Aids Research Center · R01 · FY2009 · AI
The effects of opioid use on HIV-1 reservoir dynamics
$897,477Athe M. Tsibris · Brigham And Women'S Hospital · R33 · FY2022 · DA
PURIFICATION OF HIV ENV PROTEINS WITH AN IMMUNOAFFINITY BASED PROCESS
$897,313Antu Dey · International Aids Vaccine Initiative · N01 · FY2017 · AI
Criminal Justice Drug Treatment Services Research Center
$897,298Howard A Liddle · University Of Miami School Of Medicine · U01 · FY2006 · DA
Individual, Network and Spatial Drivers of HIV and HCV among PWID in India
$897,280Sunil Suhas Solomon · Johns Hopkins University · R01 · FY2016 · DA
Project 1
$896,937John D Gross · University Of California, San Francisco · U54 · FY2024 · AI
Viral and Immune Determinants of HIV Rebound
$896,825Jonathan Li · Brigham And Women'S Hospital · R56 · FY2016 · AI
Monitoring Variation in Mixtures of Long RNAs with End-to-End RT Sequencing
$896,806Anna Marie Pyle · Yale University · R01 · FY2017 · HG
Identifying and Disseminating Substance, Treatment, and Strategy (STS) Recommendations to AIDS Service Organizations
$896,777Bryan R Garner · Research Triangle Institute · R01 · FY2021 · DA
The Role of Scavenger Receptor gp340 in Mucosal HIV-1 Transmission and Inhibition
$896,761Min Lu · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2012 · AI